$1.4 Billion in Taxpayer Funds Earmarked for Next-Gen COVID-19 Vaccines

The Biden administration has committed $1.4 billion to Project NextGen, a health initiative aimed at developing experimental COVID-19 vaccines and preparing the U.S. for future variants and global health crises.

The Biden administration has allocated $1.4 billion for the development of experimental COVID-19 vaccines as part of the “Project NextGen” health initiative.

Led by the Administration for Strategic Preparedness and Response (ASPR) and the Biomedical Advanced Research and Development Authority (BARDA), the project aims to prepare the U.S. for future COVID-19 variants and other global health emergencies.

The funding will support clinical trials, next-generation monoclonal antibodies, and new technologies for vaccine manufacturing.

This move adds to the $30 billion already spent by the U.S. government on COVID-19 vaccines.

Sharing our articles helps AFLOE survive and thrive.

Thank you for reading!

Entering your email helps us stay in contact with you in case we get shut down on other platforms.

Share this
Send this to a friend